Back to search
FDAFDA · Food and drugs·Recall number D-1404-2012

Imodium Multi-Symptom Relief Caplets, Loperamide HCl 2 mg/Simethicone 125 mg, 18 count blister pack cartons, McNeil Consumer Healthcare, Div of McNeil-PPC Inc., Fort Washington, PA

Published July 11, 2012 · Recall initiated: May 17, 2012

Summary

FDA records drug Class III recall D-1404-2012, published July 11, 2012 and initiated May 17, 2012. Recalling firm: Mcneil Consumer Healthcare, Div Of Mcneil-ppc, Inc.; Status: Terminated; Reported quantity: 53,892 packages; Lot: Lot #CMF023, Expiration 07/13. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Defective Container; damaged blister units

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Mcneil Consumer Healthcare, Div Of Mcneil-ppc, Inc.
Distributor
Nationwide
Lot
Lot #CMF023, Expiration 07/13.
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Imodium Multi-Symptom Relief Caplets, Loperamide HCl 2 mg/Simethicone 125 mg, 18 count blister pack cartons, McNeil Consumer Healthcare, Div of McNeil-PPC Inc., Fort Washington, PA recalled?

Yes. FDA published recall D-1404-2012 on July 11, 2012. Reported hazard: Defective Container; damaged blister units

What should I do if I have this product?

Voluntary: Firm initiated · Letter